UniPharma Co., Ltd. (TPEX:6621)
Taiwan · Delayed Price · Currency is TWD 11.45
0.00 (0.00%)
Sep 8, 2026, 12:51 PM CST
UniPharma Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 406 | 431 | 492 | 525 | 550 | 400 | |
Market Cap Growth | -9.84% | -12.27% | -6.42% | -4.52% | 37.73% | -25.33% |
Enterprise Value | 311 | 300 | 371 | 355 | 366 | 214 |
Last Close Price | 11.45 | 12.15 | 13.85 | 14.80 | 15.50 | 11.35 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 23.14 | 23.14 | 23.14 | 23.14 | 23.14 |
PS Ratio | 4.85 | 4.88 | 5.26 | 5.09 | 4.30 | 3.79 |
PB Ratio | 2.07 | 1.88 | 1.73 | 1.68 | 1.82 | 1.34 |
P/TBV Ratio | 2.10 | 1.91 | 1.75 | 1.69 | 1.83 | 1.35 |
P/FCF Ratio | - | - | - | 133.90 | - | - |
P/OCF Ratio | - | - | - | 43.66 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.71 | 3.39 | 3.97 | 3.44 | 2.86 | 2.03 |
EV/FCF Ratio | - | - | - | 90.52 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.06 | 0.05 | 0.05 | 0.00 | 0.01 | 0.02 |
Debt / FCF Ratio | - | - | - | 0.07 | - | - |
Net Debt / Equity Ratio | -0.48 | -0.54 | -0.50 | -0.53 | -0.52 | -0.57 |
Net Debt / EBITDA Ratio | 2.24 | 3.04 | 5.18 | 6.68 | 8.44 | 4.81 |
Net Debt / FCF Ratio | 2.72 | 3.28 | 9.42 | -42.53 | 4.95 | 12.44 |
Asset Turnover | 0.32 | 0.29 | 0.28 | 0.30 | 0.38 | 0.28 |
Inventory Turnover | 1.41 | 1.54 | 1.75 | 1.74 | 1.60 | 1.50 |
Quick Ratio | 3.77 | 3.96 | 5.25 | 5.08 | 6.82 | 4.24 |
Current Ratio | 4.85 | 4.86 | 6.03 | 6.10 | 8.28 | 5.59 |
Return on Equity (ROE) | -17.90% | -15.76% | -8.31% | -7.08% | -2.34% | -22.00% |
Return on Assets (ROA) | -10.86% | -9.13% | -5.67% | -5.00% | -3.83% | -6.58% |
Return on Invested Capital (ROIC) | -45.10% | -35.62% | -21.39% | -18.81% | -15.26% | -23.88% |
Return on Capital Employed (ROCE) | -22.50% | -18.60% | -10.40% | -8.70% | -6.90% | -13.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -9.86% | -9.40% | -5.05% | -4.15% | -1.17% | -18.62% |
FCF Yield | -8.61% | -8.80% | -3.07% | 0.75% | -5.83% | -3.39% |
Buyback Yield / Dilution | - | - | - | -0.04% | -0.81% | - |